ACE and Arrhythmia: Participants with nocturnal hypoxia were also more likely to be receiving angiotensin converting enzyme-inhibitor (ACE-I) or angiotensin receptor blockers (ARB) or cardiovascular medications (including acetylsalicylic acid, nitrates, calcium channel blockers, arrhythmia medications, and lipid-lowering agents) at the time of sleep assessment.